These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 13152194)

  • 21. The degree of inactivation of vasopressin by the kidney and the liver of rats.
    DICKER SE; GREENBAUM AL
    J Physiol; 1954 May; 124(2):35-6P. PubMed ID: 13175177
    [No Abstract]   [Full Text] [Related]  

  • 22. [The role of vasopressin and oxytocin in the regulation of glycemia levels and carbohydrate metabolism in the liver].
    Roik VI
    Ukr Biokhim Zh (1978); 1987; 59(2):73-5. PubMed ID: 3033860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pitressin toxicity in diabetes insipidus, and the therapeutic superiority of the nasal route for replacement therapy; report of a case.
    SMITH WW
    Ohio State Med J; 1957 Nov; 53(11):1277-9. PubMed ID: 13477644
    [No Abstract]   [Full Text] [Related]  

  • 24. [Aldosterone excretion and electrolyte metabolism under the action of Pitressin in non-hydrated, normal human volunteers].
    FRANKEN FH; IRMSCHER K; DAWEKE H
    Acta Endocrinol (Copenh); 1961 Sep; 38():22-30. PubMed ID: 13701416
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative study of the antidiuretic effects of Adiuretin-SD (DDAVP) and Pitressin Tannate in diabetes insipidus.
    Czakó L; Julesz J; László FA
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):10-3. PubMed ID: 631964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pitressin test of coronary insufficiency.
    RUSKIN A
    J Clin Invest; 1947 Nov; 26(6):1195. PubMed ID: 20340971
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of vasopressin (Pitressin) on gastric mucosal blood flow measured by clearance of krypton.
    Bell PR; Battersby C
    Surgery; 1969 Sep; 66(3):510-4. PubMed ID: 4896069
    [No Abstract]   [Full Text] [Related]  

  • 28. [Letter: A synthetic analog of vasopressin (DDAVP). Value in the treatment of pitressin-sensitive diabetes insipidus].
    Toursel F; Fontaine G
    Nouv Presse Med; 1975 Jan; 4(3):190. PubMed ID: 1093122
    [No Abstract]   [Full Text] [Related]  

  • 29. Failure to confirm the report that pitressin has a growth stimulating effect.
    REICHLIN S; BROWN JG
    Endocrinology; 1961 Aug; 69():394-6. PubMed ID: 13740465
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of pitressin in the treatment of schizophrenia with deterioration.
    FORIZS L
    N C Med J; 1952 Feb; 13(2):76-80. PubMed ID: 14911023
    [No Abstract]   [Full Text] [Related]  

  • 31. Accelerated appearance of DCA hypertension in rats treated with pitressin.
    FRIEDMAN SM; FRIEDMAN CL; NAKASHIMA M
    Endocrinology; 1960 Dec; 67():752-9. PubMed ID: 13702031
    [No Abstract]   [Full Text] [Related]  

  • 32. Pitressin test of coronary insufficiency.
    RUSKIN A
    Am Heart J; 1947 Oct; 34(4):569-79. PubMed ID: 20266470
    [No Abstract]   [Full Text] [Related]  

  • 33. Histologic alterations in the adrenal cortex of intact and hypophysectomized rats following ACTH, pitressin and adrenal steroids.
    WEXLER BC
    Endocrinology; 1963 Jan; 72():149-58. PubMed ID: 14000171
    [No Abstract]   [Full Text] [Related]  

  • 34. Hereditary pitressin-resistant diabetes insipidus.
    CARRE IJ; McCOY JE
    Acta Paediatr (Stockh); 1959 May; 48(3):223-32. PubMed ID: 13649344
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevention of hyponatraemia and cerebral oedema by the vasopressin antagonist d/CH2/5Tyr/Et/VAVP in rats treated with pitressin tannate.
    László FA; Csáti S; Baláspiri L
    Acta Endocrinol (Copenh); 1984 May; 106(1):56-60. PubMed ID: 6730855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of diabetes insipidus by the buccal administration of posterior pituitary powder (pitressin).
    KLEIN R; LARON Z
    J Clin Endocrinol Metab; 1957 Mar; 17(3):445-8. PubMed ID: 13406006
    [No Abstract]   [Full Text] [Related]  

  • 37. Local gangrene: a complication of peripheral Pitressin therapy for bleeding esophageal varices.
    Greenwald RA; Rheingold OJ; Chiprut RO; Rogers AI
    Gastroenterology; 1978 Apr; 74(4):744-6. PubMed ID: 305380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pitressin tannate in oil as a hemostatic agent in gastro-intestinal bleeding.
    MOEHLIG RC
    Harper Hosp Bull; 1954; 12(4):138-9. PubMed ID: 13232531
    [No Abstract]   [Full Text] [Related]  

  • 39. Imprinting with oxytocin and vasopressin in Chang liver cell cultures: hormonal overlap, binding and influence on cell division.
    Bohdaneczky E; Csaba G; Csiky J; Köhidai L
    Acta Physiol Hung; 1988; 71(1):35-40. PubMed ID: 2839005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Coronary circulation. 2. Coronary resistance, (3) propranolol (Indersal), (4) dipyridamole (Persantin) and vasopressin (Pitressin)].
    Saito T
    Masui; 1972 May; 21(5):479-86. PubMed ID: 4561562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.